Financhill
Buy
61

AZN Quote, Financials, Valuation and Earnings

Last price:
$92.48
Seasonality move :
1.93%
Day range:
$92.01 - $92.61
52-week range:
$61.24 - $94.02
Dividend yield:
1.69%
P/E ratio:
30.71x
P/S ratio:
4.97x
P/B ratio:
6.25x
Volume:
3.5M
Avg. volume:
5.5M
1-year change:
39.44%
Market cap:
$286.7B
Revenue:
$54.1B
EPS (TTM):
$3.01

Earnings Data

Next earnings date for AZN
Feb 10
2026
Most recent earnings per share
$0.81
Missed by $0.33
(Nov 6/2025)
Consensus Estimate
$1.13
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AZN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/10/2026 Q4 $15.4B -- -- $1.09 --
11/06/2025 Q3 $14.8B $15.1B $0.81 $1.13 -$0.33
07/29/2025 Q2 $14.1B $14.6B $0.80 $1.46 -$0.67
04/29/2025 Q1 $13.7B $13.6B $0.93 $1.12 -$0.18
02/06/2025 Q4 $14.2B $14.8B $0.48 $1.04 -$0.56
11/12/2024 Q3 $13.1B $13.6B $0.46 $1.03 -$0.57
07/25/2024 Q2 $12.5B $12.9B $0.62 $0.99 -$0.38
04/25/2024 Q1 $11.8B $12.7B $0.70 $0.95 -$0.25
02/08/2024 Q4 $12B $12B $0.31 $0.76 -$0.46
11/09/2023 Q3 $11.5B $11.5B $0.44 $0.82 -$0.38
07/28/2023 Q2 -- $11.4B $0.58 -- --
04/27/2023 Q1 -- $10.9B $0.58 -- --
02/09/2023 Q4 -- $11.2B $0.29 -- --
11/10/2022 Q3 -- $11B $0.53 -- --
07/29/2022 Q2 -- $10.8B $0.12 -- --
04/29/2022 Q1 -- $11.4B $0.12 -- --
02/10/2022 Q4 -- $12.1B -$0.11 -- --
11/12/2021 Q3 -- $9.9B -$0.55 -- --
07/29/2021 Q2 -- $8.2B $0.21 -- --
04/30/2021 Q1 -- $8.4B $0.59 -- --
02/11/2021 Q4 -- $7.9B $0.39 -- --
11/05/2020 Q3 -- $6.7B $0.25 -- --
07/30/2020 Q2 -- $6.3B $0.29 -- --
04/29/2020 Q1 -- $6.7B $0.30 -- --
02/14/2020 Q4 -- $7.1B $0.12 -- --
10/24/2019 Q3 -- $6.6B $0.11 -- --
07/25/2019 Q2 -- $5.8B $0.05 -- --
04/26/2019 Q1 -- $6B $0.23 -- --
02/14/2019 Q4 -- $7.2B $0.41 -- --
11/08/2018 Q3 -- $5.7B $0.17 -- --
07/26/2018 Q2 -- $5.7B $0.14 -- --
05/18/2018 Q1 -- $5.2B $0.14 -- --
02/02/2018 Q4 -- $5.8B $0.52 -- --
11/09/2017 Q3 -- $6.2B $0.27 -- --
07/27/2017 Q2 -- $5.1B $0.19 -- --
04/27/2017 Q1 -- $5.4B $0.21 -- --
02/02/2017 Q4 -- $5.6B $0.73 -- --
11/10/2016 Q3 -- $5.7B $0.40 -- --
07/28/2016 Q2 -- $5.5B -$0.00 -- --
04/29/2016 Q1 -- $6.1B $0.25 -- --
02/04/2016 Q4 -- $6.4B $0.32 -- --

AstraZeneca PLC Earnings Questions

  • How Much did AstraZeneca PLC Generate in Revenue Last Quarter?

    AstraZeneca PLC reported $15.1B worth of top line sales in its most recent quarter.

  • Did AstraZeneca PLC Beat Earnings Last Quarter?

    AstraZeneca PLC announced earnings per share of $0.81 which represents a miss of analyst forecast a $1.13 per share.

  • Is AstraZeneca PLC Profitable?

    AstraZeneca PLC reported $11.2B that represents $3.57 per share over the last quarter.

  • What is the Analyst Consensus for AstraZeneca PLC EPS Next Year?

    AstraZeneca PLC's earnings are forecast to grow from $2.25 per share to $4.10 per share next year representing an increase of 104%.

  • When is AstraZeneca PLC's Earnings Date?

    AstraZeneca PLC's next earnings date is February 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock